EyePoint, Inc. Paid-in-Kind Interest
EyePoint, Inc. (EYPT) reported Paid-in-Kind Interest of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2022-03-14
- EyePoint, Inc. paid-in-kind interest for the quarter ending 2021-12-31 was $0.00.
- EyePoint, Inc. paid-in-kind interest for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. paid-in-kind interest for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. paid-in-kind interest for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- EyePoint, Inc. paid-in-kind interest for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- EyePoint, Inc. paid-in-kind interest for fiscal 2020 was $977.00K, a 7.13% decline from fiscal 2019.
- EyePoint, Inc. paid-in-kind interest for fiscal 2019 was $1.05M.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $0.00 derived: sum of 2 quarters · filed 2022-03-14 | $0.00 derived: sum of 3 quarters · filed 2022-03-14 | $0.00 10-K · filed 2022-03-14 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | $0.00 derived: sum of 4 quarters · filed 2022-03-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | $0.00 derived: sum of 3 quarters · filed 2022-03-14 | $330.00K derived: sum of 4 quarters · filed 2022-03-14 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-03-14 | $330.00K derived: sum of 3 quarters · filed 2022-03-14 | $654.00K derived: sum of 4 quarters · filed 2022-03-14 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $330.00K derived: sum of 2 quarters · filed 2022-03-14 | $654.00K derived: sum of 3 quarters · filed 2022-03-14 | $977.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $654.00K derived: sum of 2 quarters · filed 2021-11-05 | $977.00K 10-Q · filed 2021-11-05 | $1.30M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $324.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $647.00K 10-Q · filed 2021-08-06 | $971.00K derived: sum of 3 quarters · filed 2021-08-06 | $1.29M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $323.00K 10-Q · filed 2021-05-05 | $647.00K derived: sum of 2 quarters · filed 2021-05-05 | $969.00K derived: sum of 3 quarters · filed 2021-05-05 | $1.26M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $646.00K derived: sum of 2 quarters · filed 2021-03-12 | $940.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.05M 10-K · filed 2021-03-12 |
| 2019-09-30 | $322.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $616.00K derived: sum of 2 quarters · filed 2020-11-06 | $728.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $406.00K 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $112.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |